Kezarlifesciences

Kezar is a clinical-stage biopharmaceutical company that engages in developing novel small molecule therapeutics for autoimmune diseases.

Business Model:

Revenue: $0

Employees: 51-200

Detailed Kezarlifesciences Information

Geographic Data

Kezarlifesciences headquarters map

Address: 300 Utah Ave Ste 105

City: South San Francisco

State: CA

Zip: 94080

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$50M

Raised Total:

$123M

Metrics

3,594,928Website Global Rank

3,751Website Monthly Traffic

Twitter Followers

Description

Kezar is a clinical-stage biopharmaceutical company that engages in developing novel small molecule therapeutics for autoimmune diseases.

Contact Phone:
+16508225600

Contact Email:

Kezarlifesciences went public on 6/20/2018 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/20/2018

Ticker Symbol:
KZR

IPO Price:
$15/share

Amount Raised:
$75M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
6/2017 Series B $50M Morningside Venture
Cowen Healthcare Investments
Pappas Ventures
Qiming Venture Partners
Bay City Capital
EcoR1 Capital
Omega Funds
Aju IB Investment
7/2017 Series B $0 Omega Funds
Pappas Ventures
Bay City Capital
Cormorant Asset Management
Cowen Group
Morningside Group
Qiming Venture Partners
Chiesi Ventures
Cormorant Asset Management
Morningside Group
Aju IB Investment
EcoR1 Capital
Omega Funds
Pappas Ventures
Bay City Capital
Cormorant Asset Management
Cowen Group
Morningside Group
Qiming Venture Partners
Chiesi Ventures
Cormorant Asset Management
Morningside Group
Aju IB Investment
EcoR1 Capital
1/2020 Post-IPO Equity 1 - Solasta Ventures
Solasta Ventures
11/2021 Post-IPO Debt 1 $50M Oxford Finance LLC
Oxford Finance LLC
6/2018 IPO $75M
6/2015 Series A $28.4M Morningside Venture
EcoR1 Capital
Omega Funds
Aju IB Investment
6/2015 Series A 7 $23M Omega Funds
Morningside Group
KittyHawk Ventures
EcoR1 Capital
Cormorant Asset Management
Aju IB Investment
9W Capital Management
1/2020 Post-IPO Equity 1 - Solasta Ventures
Solasta Ventures
7/2017 Series B 10 $50M Omega Funds
Pappas Ventures
Bay City Capital
Cormorant Asset Management
Cowen Group
Morningside Group
Qiming Venture Partners
Chiesi Ventures
Cormorant Asset Management
Morningside Group
Omega Funds
Pappas Ventures
Bay City Capital
Cormorant Asset Management
Cowen Group
Morningside Group
Qiming Venture Partners
Chiesi Ventures
Cormorant Asset Management
Morningside Group
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research